Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Felix Wussow,Elaine Tran,Joy Martinez,Jose Ortiz,Andreas Herrmann,Maegan Newell,Rana Chakraborty,Erica Johnson,Flavia Chiuppesi,Don J Diamond,Peter A Barry,Corinna La Rosa,John Campo,Jeff Longmate,Christin Flechsig

doi:10.1371/journal.ppat.1004524

Abstract

Human Cytomegalovirus (HCMV) utilizes two different pathways for host cell entry. HCMV entry into fibroblasts requires glycoproteins gB and gH/gL, whereas HCMV entry into epithelial and endothelial cells (EC) requires an additional complex composed of gH, gL, UL128, UL130, and UL131A, referred to as the gH/gL-pentamer complex (gH/gL-PC). While there are no established correlates of protection against HCMV, antibodies are thought to be important in controlling infection. Neutralizing antibodies (NAb) that prevent gH/gL-PC mediated entry into EC are candidates to be assessed for in vivo protective function. However, these potent NAb are predominantly directed against conformational epitopes derived from the assembled gH/gL-PC. To address these concerns, we constructed Modified Vaccinia Ankara (MVA) viruses co-expressing all five gH/gL-PC subunits (MVA-gH/gL-PC), subsets of gH/gL-PC subunits (gH/gL or UL128/UL130/UL131A), or the gB subunit from HCMV strain TB40/E. We provide evidence for cell surface expression and assembly of complexes expressing full-length gH or gB, or their secretion when the corresponding transmembrane domains are deleted. Mice or rhesus macaques (RM) were vaccinated three times with MVA recombinants and serum NAb titers that prevented 50% infection of human EC or fibroblasts by HCMV TB40/E were determined. NAb responses induced by MVA-gH/gL-PC blocked HCMV infection of EC with potencies that were two orders of magnitude greater than those induced by MVA expressing gH/gL, UL128-UL131A, or gB. In addition, MVA-gH/gL-PC induced NAb responses that were durable and efficacious to prevent HCMV infection of Hofbauer macrophages, a fetal-derived cell localized within the placenta. NAb were also detectable in saliva of vaccinated RM and reached serum peak levels comparable to NAb titers found in HCMV hyperimmune globulins. This vaccine based on a translational poxvirus platform co-delivers all five HCMV gH/gL-PC subunits to achieve robust humoral responses that neutralize HCMV infection of EC, placental macrophages and fibroblasts, properties of potential value in a prophylactic vaccine.

Highlights

Human Cytomegalovirus (HCMV) infection causes morbidity and mortality in vulnerable hosts following horizontal or vertical transmission [1]
We used as a model our recently described bacterial artificial chromosome (BAC)-derived Modified Vaccinia Ankara (MVA) vaccine vector for rhesus cytomegalovirus (RhCMV) gH/gL-PC, to rapidly and efficiently construct a single MVA vector expressing all five HCMV gH/gLPC subunits [46]. gH/gL-PC subunits were derived from HCMV TB40/E, a well-characterized clinical-like HCMV strain with an intact complement of gH/gL-PC genes [49]
To provide a comparative basis for evaluating the Neutralizing antibodies (NAb) responses elicited by immunization with MVA-gH/gL-PC and MVA-gH/gL-PCD, MVA vectors expressing full-length gH/gL (MVA-gH/gL), UL128/UL130/UL131A (MVA-UL128-131), full-length glycoprotein B (gB) (MVA-gB), and TM-deleted gB (MVA-gBD) were constructed (Figure 1B and 1C). gO is known to associate with gH/gL and to contribute to the endoplasmic reticulum transport of these proteins, anchoring either gH/gL or gH/gL/gO complexes within the virion envelope [50,51]

Summary

Introduction

HCMV infection causes morbidity and mortality in vulnerable hosts following horizontal or vertical transmission [1]. Multi-system life-threatening disease can occur with primary infection, reinfection by a different HCMV strain, or after viral reactivation. HCMV is the most common congenital infection worldwide (0.2–2.0% of all pregnancies) often resulting in long-term consequences to the developing fetus including mortality [2,3]. Intrauterine HCMV has a marked tropism for the developing central nervous system, and a consequence of congenital infection can be irrevocable neurological sequelae in newborns. In 1999, the Institute of Medicine ranked HCMV infection in the highest category for vaccine preventable diseases because potential societal benefits from reduction in associated morbidity and mortality would far outweigh development costs [6].

Methods

Results

Conclusion